Sun Pharmaceutical Industries Limited

Ranbaxy Laboratories, Inc.

Ravish Sharma

Romi Barat Singh

Anuj Kumar Fanda

Satish Kumar Jain

Rajesh Srikrishan Shear

Pulak Kumar Metia

Ravinder Singh

Swarna Pappu

Prabhakar Konatham

Pruthvipathy Katikaneni

Dileep Jami

Shavej Ahmad

Ajay Kumar Singla

Kumaravel Vivek

Lalit Kumar Khurana

The present invention relates to a pharmaceutical gastro-retentive solid oral dosage form comprising nilotinib as the active ingredient. The invention is further related to methods of preparing said dosage form.

Pharmaceutical gastro-retentive solid oral dosage form of nilotinib

The present invention relates to a once daily pharmaceutical composition comprising doxycycline and one or more pharmaceutically acceptable excipients, wherein the pharmaceutical composition exhibits a reduced food effect. The invention further provides a method of treatment of rosacea by administering to a person in need thereof the doxycycline pharmaceutical composition with or without food. A process of preparing such pharmaceutical composition is also provided.

Pharmaceutical composition of doxycycline with reduced food effect

The present invention relates to a once daily pharmaceutical composition comprising doxycycline, a controlled-release polymer, and one or more pharmaceutically acceptable excipients. The invention further provides a method of treatment of rosacea by administering such pharmaceutical composition. A process of preparing such pharmaceutical composition is also provided.

Doxycycline composition

The present invention relates to a once daily tablet comprising doxycycline at sub-antibiotic dose and one or more pharmaceutically acceptable excipients, wherein the tablet exhibits a reduced food effect. The invention further provides a method of treatment of rosacea by administering to a person in need thereof the doxycycline tablet with or without food. A process of preparing the tablet is also provided.

The present invention relates to a pharmaceutical composition comprising (i) 50% to 99% of doxycycline as an immediate-release portion; (ii) 1% to 50% of doxycycline as a controlled-release portion; and (iii) one or more pharmaceutically acceptable excipients; wherein the pharmaceutical composition provides a total daily dosage of 40 mg when administered once daily. It also relates to process for preparation of the pharmaceutical composition and its use for treating rosacea.

Pharmaceutical composition of doxycycline

Growing community of inventors

Khargone, India

Ravish Sharma